Neuland Laboratories Ltd (NEULANDLAB)

Company profile

Sector

Pharmaceuticals

Industry

Pharmaceuticals & Biotechnology

Market cap (₹ Cr)

28,899.32

Neuland Laboratories Ltd. engages in the manufacture and export of bulk pharmaceutical ingredients and intermediates for the generics industry. The company is headquartered in Hyderabad, Telangana and currently employs 1,521 full-time employees. The firm is engaged in manufacturing and selling of bulk drugs and caters to both domestic and international markets. The firm operates through manufacture of active pharmaceutical ingredients and allied services. The firm has two business verticals: generic drug substances (GDS) and custom manufacturing solutions (CMS). Its products and services include Levetiracetam, Mirtazapine, Ciprofloxacin, Enalapril, Sotalol, Labetalol and Custom Manufacturing Services. The Company’s capabilities include FBRM, research and development, peptide laboratory, poly block reactors, laboratory reactors, heating and cooling systems, hazardous and wet laboratory, PID Laboratory Unit-III, PID Laboratory B-S Unit-I, and other lab equipment. The firm has 3 manufacturing facilities and one R&D facility in Hyderabad.

Source: finedge · as of 2026-09-29

Price, last year

Last close (₹): 18,935

Source: quantro_screener_metrics_job · as of 2026-10-22

Key figures

P/E

66.74

52-week high

24,225

52-week low

11,500

Revenue CAGR, 3 years (%)

19.31

Revenue CAGR, 5 years (%)

16.64

EPS CAGR, 3 years (%)

30.57

EPS CAGR, 5 years (%)

35.18

Source: quantro_screener_metrics_job · as of 2026-10-23

Annual summary

Source: finedge · as of 2026-07-21

Shareholding and promoter pledge

Promoter

32.63%

FII

20.46%

DII

15.84%

Public

31.07%

Promoter shares pledged

2.3%

Source: finedge · as of 2026-03-31

Similar companies

• Sai Life Sciences Ltd₹ 30,046.96 Cr
• Piramal Pharma Ltd₹ 26,061.14 Cr
• Wockhardt Ltd₹ 33,525.38 Cr
• Pfizer Ltd₹ 21,595.44 Cr
• Granules India Ltd₹ 21,585.59 Cr
• Emcure Pharmaceuticals Ltd₹ 36,550.41 Cr

Source: quantro_company_profiles · as of 2026-10-23

Frequently asked questions

What does Neuland Laboratories Ltd do?

Neuland Laboratories Ltd. engages in the manufacture and export of bulk pharmaceutical ingredients and intermediates for the generics industry. The company is headquartered in Hyderabad, Telangana and currently employs 1,521 full-time employees. The firm is engaged in manufacturing and selling of bulk drugs and caters to both domestic and international markets. The firm operates through manufacture of active pharmaceutical ingredients and allied services. The firm has two business verticals: generic drug substances (GDS) and custom manufacturing solutions (CMS). Its products and services include Levetiracetam, Mirtazapine, Ciprofloxacin, Enalapril, Sotalol, Labetalol and Custom Manufacturing Services. The Company’s capabilities include FBRM, research and development, peptide laboratory, poly block reactors, laboratory reactors, heating and cooling systems, hazardous and wet laboratory, PID Laboratory Unit-III, PID Laboratory B-S Unit-I, and other lab equipment. The firm has 3 manufacturing facilities and one R&D facility in Hyderabad.

Which sector is Neuland Laboratories Ltd in?

Neuland Laboratories Ltd is in the Pharmaceuticals sector, Pharmaceuticals & Biotechnology industry.

What are Neuland Laboratories Ltd's latest annual revenue and profit?

For the year ended Mar 2026: revenue 2022.99 Cr, profit after tax 364.00 Cr.

What is the promoter holding and pledge in Neuland Laboratories Ltd?

Promoter holding is 32.63%; pledged shares are 2.30% of the promoter holding.

Which companies are similar to Neuland Laboratories Ltd?

Companies in the same sector of similar size: Sai Life Sciences Ltd, Piramal Pharma Ltd, Wockhardt Ltd, Pfizer Ltd, Granules India Ltd, Emcure Pharmaceuticals Ltd.